Intravenous antiarrhythmic agents

Current Opinion in Cardiology

Volumn 16, Issue 1, 2001, Pages 17-22

  Pinter, Arnold ^a   Dorian, Paul ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRETYLIUM; DOFETILIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; LIDOCAINE; PLACEBO; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL;

ACUTE HEART INFARCTION; BRUGADA SYNDROME; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SICK SINUS SYNDROME; SUPRAVENTRICULAR TACHYCARDIA;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; INFUSIONS, INTRAVENOUS; PROCAINAMIDE; PROPAFENONE; TACHYCARDIA, VENTRICULAR;

EID: 0035167577     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200101000-00003     Document Type: Review

References (56)

1. Adenosine as an antiarrhythmic agent
2. The International Guidelines 2000 for CPR and ECC
3. Adenosine-induced atrial fibrillation
4. Use of intravenous adenosine as a noninvasive diagnostic test for sick sinus syndrome
5. Simplified "ATP test" for noninvasive diagnosis of dual AV nodal physiology and assessment of results of slow pathway ablation in patients with AV nodal reentrant tachycardia
6. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts
7. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls
8. Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects
9. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation
10. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation
11. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: Electrophysiologic determinants of enhanced conversion efficacy
12. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation
13. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery
14. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
15. Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: A placebo-controlled study
16. Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery
17. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm
18. Atrial flutter in patients treated for atrial fibrillation with propafenone
19. Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: A placebo-controlled study
20. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: Results of a randomized, controlled study
21. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation
22. Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm
23. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: The effect of no treatment and highdose amiodarone. A randomized, placebo-controlled study
24. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter
25. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled trial
26. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter
27. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicenter, randomized, double-blind, placebo-controlled study
28. Acute hemodynamic effects of intravenous ibutilide in patients with or without reduced left ventricular function
29. Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation
30. Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation
31. Cost-effective strategies in the · acute management of atrial fibrillation
32. Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks
33. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery
34. Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure
35. Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias
36. Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery
37. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: The Amiodarone Reduction in Coronary Heart (ARCH) trial
38. Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
39. Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations
40. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia
41. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia
42. Treatment of torsade de pointes with magnesium sulfate
43. Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction
44. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from the randomized, controlled trials
45. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction
46. Prophylactic lidocaine use in acute myocardial infarction: Incidence and outcomes from two international trials
47. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction
48. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol
49. The role of intravenous amiodarone in the management of cardiac arrhythmias
50. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias
51. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation
52. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias
53. Efficacy and tolerance of highdose intravenous amiodarone for recurrent, refractory ventricular tachycardia
54. Treating electrical storm: Sympathetic blockade versus advanced cardiac life support-guided therapy
55. Amiodarone for the OTAC Study Group: Do advanced cardiac life support drugs increase resuscitation rates from inhospital cardiac arrest?
56. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation